AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 121 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,597 | +18.0% | 3,155,427 | -5.3% | 0.01% | +50.0% |
| Q2 2023 | $3,048 | +132.7% | 3,330,727 | +42.4% | 0.00% | +100.0% |
| Q1 2023 | $1,310 | -21.3% | 2,338,500 | -19.0% | 0.00% | 0.0% |
| Q4 2022 | $1,665 | -99.8% | 2,886,227 | -4.3% | 0.00% | +100.0% |
| Q3 2022 | $954,000 | +82.4% | 3,016,427 | +103.5% | 0.00% | 0.0% |
| Q2 2022 | $523,000 | -27.4% | 1,482,300 | +47.7% | 0.00% | 0.0% |
| Q1 2022 | $720,000 | -48.9% | 1,003,327 | +61.0% | 0.00% | -50.0% |
| Q4 2021 | $1,408,000 | -48.5% | 623,027 | -34.4% | 0.00% | -50.0% |
| Q3 2021 | $2,736,000 | -60.5% | 949,927 | -48.0% | 0.00% | -55.6% |
| Q2 2021 | $6,927,000 | +91.1% | 1,827,730 | +70.7% | 0.01% | +80.0% |
| Q1 2021 | $3,624,000 | -10.6% | 1,070,581 | -26.1% | 0.01% | +25.0% |
| Q4 2020 | $4,054,000 | +2203.4% | 1,447,927 | +1963.3% | 0.00% | – |
| Q3 2020 | $176,000 | -82.9% | 70,175 | -7.3% | 0.00% | -100.0% |
| Q2 2020 | $1,028,000 | +17.5% | 75,689 | -45.4% | 0.00% | 0.0% |
| Q4 2019 | $875,000 | +414.7% | 138,527 | +219.0% | 0.00% | – |
| Q3 2019 | $170,000 | -98.9% | 43,427 | -97.6% | 0.00% | -100.0% |
| Q3 2018 | $15,691,000 | -63.3% | 1,776,971 | -59.6% | 0.02% | -30.4% |
| Q2 2018 | $42,716,000 | +77.9% | 4,393,700 | +74.4% | 0.02% | -11.5% |
| Q1 2018 | $24,007,000 | -11.4% | 2,519,100 | +38.3% | 0.03% | -13.3% |
| Q4 2017 | $27,081,000 | -3.1% | 1,821,200 | +28.2% | 0.03% | -9.1% |
| Q3 2017 | $27,949,000 | +89.7% | 1,420,900 | +38.6% | 0.03% | +73.7% |
| Q2 2017 | $14,734,000 | +314.6% | 1,025,300 | +165.4% | 0.02% | +280.0% |
| Q1 2017 | $3,554,000 | +63.6% | 386,267 | +85.2% | 0.01% | +66.7% |
| Q4 2016 | $2,172,000 | +58.1% | 208,600 | +37.4% | 0.00% | +50.0% |
| Q3 2016 | $1,374,000 | +654.9% | 151,800 | +524.7% | 0.00% | – |
| Q2 2016 | $182,000 | -29.2% | 24,300 | -14.7% | 0.00% | – |
| Q1 2016 | $257,000 | -81.8% | 28,500 | -73.9% | 0.00% | -100.0% |
| Q4 2015 | $1,411,000 | +32.0% | 109,200 | -1.4% | 0.00% | 0.0% |
| Q3 2015 | $1,069,000 | -72.8% | 110,700 | -71.0% | 0.00% | -66.7% |
| Q2 2015 | $3,923,000 | – | 381,239 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 16,205,119 | $18,473,836 | 31.57% |
| ACADIAN ASSET MANAGEMENT LLC | 7,223,488 | $8,233 | 0.04% |
| Orchard Capital Management, LLC | 66,826 | $76,182 | 0.03% |
| XTX Topco Ltd | 138,506 | $157,897 | 0.03% |
| State of Wyoming | 74,010 | $84,371 | 0.02% |
| WEALTH EFFECTS LLC | 29,500 | $33,630 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,719,061 | $1,959,730 | 0.01% |
| James J. Burns & Company, LLC | 24,542 | $28 | 0.01% |
| Eudaimonia Partners, LLC | 27,144 | $30,945 | 0.01% |
| SYKON CAPITAL LLC | 15,000 | $17,100 | 0.01% |